A trial to investigate benralizumab in children with eosinophilic diseases

Trial Identifier:	D3255C00004
Sponsor:	AstraZeneca
Start Date:	April 2025
Primary Completion Date:	October 2026
Study Completion Date:	May 2028

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
BR	Sao Paulo, BR, 01232-010
CA, Ontario	Toronto, Ontario, CA, M5G1X8
MX	Guadalajara, MX, 44620
TR	Altındağ, TR, 06230
TR	Istanbul, TR, 34093
US, CO	Aurora, CO, US, 80045

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.